PL101880B1 - A method of producing new derivatives of erytromycin - Google Patents

A method of producing new derivatives of erytromycin Download PDF

Info

Publication number
PL101880B1
PL101880B1 PL1976188538A PL18853876A PL101880B1 PL 101880 B1 PL101880 B1 PL 101880B1 PL 1976188538 A PL1976188538 A PL 1976188538A PL 18853876 A PL18853876 A PL 18853876A PL 101880 B1 PL101880 B1 PL 101880B1
Authority
PL
Poland
Prior art keywords
group
erythromycylamine
carbon atoms
general formula
condensation product
Prior art date
Application number
PL1976188538A
Other languages
English (en)
Polish (pl)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25768725&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL101880(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE2515075A external-priority patent/DE2515075C2/de
Priority claimed from DE19762606030 external-priority patent/DE2606030A1/de
Application filed filed Critical
Publication of PL101880B1 publication Critical patent/PL101880B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL1976188538A 1975-04-07 1976-04-06 A method of producing new derivatives of erytromycin PL101880B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2515075A DE2515075C2 (de) 1975-04-07 1975-04-07 Erythromycinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19762606030 DE2606030A1 (de) 1976-02-14 1976-02-14 Neue erythromycinderivate und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
PL101880B1 true PL101880B1 (pl) 1979-02-28

Family

ID=25768725

Family Applications (1)

Application Number Title Priority Date Filing Date
PL1976188538A PL101880B1 (pl) 1975-04-07 1976-04-06 A method of producing new derivatives of erytromycin

Country Status (29)

Country Link
US (1) US4048306A (OSRAM)
JP (1) JPS51128991A (OSRAM)
AT (1) AT342770B (OSRAM)
AU (1) AU498418B2 (OSRAM)
BG (1) BG27380A3 (OSRAM)
CA (1) CA1060005A (OSRAM)
CH (2) CH621800A5 (OSRAM)
CS (1) CS196304B2 (OSRAM)
DD (1) DD125218A5 (OSRAM)
DK (1) DK138656C (OSRAM)
ES (2) ES446737A1 (OSRAM)
FI (1) FI63244C (OSRAM)
FR (1) FR2306703A1 (OSRAM)
GB (1) GB1520963A (OSRAM)
GR (1) GR60374B (OSRAM)
HU (1) HU175186B (OSRAM)
IE (1) IE43598B1 (OSRAM)
IL (1) IL49359A (OSRAM)
LU (2) LU74702A1 (OSRAM)
MX (1) MX3277E (OSRAM)
NL (1) NL180107C (OSRAM)
NO (1) NO141411C (OSRAM)
NZ (1) NZ180529A (OSRAM)
PL (1) PL101880B1 (OSRAM)
PT (1) PT64977B (OSRAM)
RO (1) RO68441B (OSRAM)
SE (1) SE425566B (OSRAM)
SU (1) SU682134A3 (OSRAM)
YU (1) YU87676A (OSRAM)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4847242A (en) 1985-03-12 1989-07-11 Beecham Group P.L.C. 11-ether derivatives of erythromycins
DE3524572A1 (de) * 1985-07-10 1987-01-15 Thomae Gmbh Dr K Feste arzneimittelformen zur peroralen anwendung enthaltend 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)-oxy)-(9s)-erythromycin und verfahren zu ihrer herstellung
US5110800A (en) * 1986-02-18 1992-05-05 Eli Lilly And Company Derivatives of erythromycylamine
US4945080A (en) * 1987-05-26 1990-07-31 Eli Lilly And Company Dirithromycin metabolite
US5075289A (en) * 1988-06-07 1991-12-24 Abbott Laboratories 9-r-azacyclic erythromycin antibiotics
KR0166096B1 (ko) * 1990-11-28 1999-01-15 우에하라 아키라 6-0-메틸에리쓰로마이신 a 유도체
ZA922776B (en) * 1991-04-29 1993-10-15 Lilly Co Eli Pharmaceutical compounds
US5556839A (en) * 1991-04-29 1996-09-17 Eli Lilly And Company Form II Dirithromycin
MY113261A (en) * 1991-09-30 2002-01-31 Lilly Co Eli One step process for production of dirithromycin.
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
DE4410637C1 (de) * 1994-03-26 1995-09-21 Boehringer Ingelheim Vetmed Injizierbare Lösungen von Dirithromycin
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
AU9645998A (en) * 1997-10-29 1999-05-17 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6541014B2 (en) 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6436906B1 (en) 2001-04-02 2002-08-20 Enanta Pharmaceuticals, Inc. 9-amino-14-membered macrolides derived from leucomycins
CA2533292C (en) 2003-07-21 2013-12-31 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
EP1648418A4 (en) 2003-07-21 2011-11-16 Middlebrook Pharmaceuticals Inc ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION
WO2005009365A2 (en) 2003-07-21 2005-02-03 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
CA2535177A1 (en) 2003-08-11 2005-02-24 Advancis Pharmaceutical Corporation Robust pellet
US8062672B2 (en) 2003-08-12 2011-11-22 Shionogi Inc. Antibiotic product, use and formulation thereof
CA2535780A1 (en) * 2003-08-29 2005-03-17 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
CA2538064C (en) 2003-09-15 2013-12-17 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
US8715727B2 (en) 2004-07-02 2014-05-06 Shionogi Inc. Tablet for pulsed delivery
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8299052B2 (en) * 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3660376A (en) * 1970-09-30 1972-05-02 Lilly Co Eli N-arylidene erythromycylamines

Also Published As

Publication number Publication date
DK138656C (da) 1979-04-02
NO141411B (no) 1979-11-26
FI63244B (fi) 1983-01-31
RO68441A (ro) 1983-04-29
HU175186B (hu) 1980-05-28
SE425566B (sv) 1982-10-11
MX3277E (es) 1980-08-15
ES446737A1 (es) 1977-10-16
PT64977B (de) 1978-04-03
FR2306703A1 (fr) 1976-11-05
ES456567A1 (es) 1978-03-01
NO141411C (no) 1980-03-05
IE43598L (en) 1976-10-07
SU682134A3 (ru) 1979-08-25
ATA149976A (de) 1977-08-15
NL180107B (nl) 1986-08-01
IL49359A0 (en) 1976-06-30
LU88563I2 (fr) 1995-03-21
CH624413A5 (OSRAM) 1981-07-31
PT64977A (de) 1976-05-01
AU498418B2 (en) 1979-03-15
NL180107C (nl) 1987-01-02
CS196304B2 (en) 1980-03-31
DK138656B (da) 1978-10-09
AU1272276A (en) 1977-10-13
NZ180529A (en) 1978-09-20
LU74702A1 (OSRAM) 1977-06-03
RO68441B (ro) 1983-04-30
FI63244C (fi) 1983-05-10
NO761172L (OSRAM) 1976-10-08
DK145276A (da) 1976-10-08
JPS51128991A (en) 1976-11-10
GR60374B (en) 1978-05-23
IE43598B1 (en) 1981-04-08
FR2306703B1 (OSRAM) 1979-10-12
YU87676A (en) 1982-08-31
BG27380A3 (bg) 1979-10-12
IL49359A (en) 1979-07-25
US4048306A (en) 1977-09-13
CH621800A5 (OSRAM) 1981-02-27
FI760845A7 (OSRAM) 1976-10-08
GB1520963A (en) 1978-08-09
JPS62158B2 (OSRAM) 1987-01-06
AT342770B (de) 1978-04-25
CA1060005A (en) 1979-08-07
DD125218A5 (de) 1977-04-06
SE7604052L (sv) 1976-10-08
NL7603569A (nl) 1976-10-11

Similar Documents

Publication Publication Date Title
PL101880B1 (pl) A method of producing new derivatives of erytromycin
JP3334980B2 (ja) 新規なエリスロマイシン誘導体、それらの製造法及びそれらの薬剤としての用途
Pakrashi et al. Studies on indian medicinal plants—VI: Structures of glycosmicine, glycorine and glycosminine, the minor alkaloids from Glycosmis arborea (roxb.) DC
CZ244490A3 (en) Derivatives of aminophenol and process for preparing thereof
CS208798B2 (en) Method of making the new derivatives of the n-substituted aziridin-2-carboxyl acid
HU190541B (en) Process for preparing disubstituted proline derivatives
RU2129546C1 (ru) 6,9-бис(аминозамещенные)-бензо(g)изохинолин-5,10-дионы, способ их получения, фармацевтическая композиция на их основе и способ ингибирования опухолей у млекопитающих
DE69105572T2 (de) 4-Phenylphthalazin-Derivate.
AU759618B2 (en) Tan-1057 derivatives
JPS5973599A (ja) Ｃ−２０−修飾マクロライド誘導体
WO2011013735A1 (ja) 新規フラバノン誘導体
JPS60126284A (ja) ピリドンカルボン酸誘導体およびその塩
US4080380A (en) 2-Naphthyl-lower-alkylamines
JPS61100564A (ja) ペプチドで置換された複素環免疫促進剤
FR2461705A1 (fr) Nouveaux derives de 1-(4-aminobenzyl)-2,3-dioxopiperazine et leurs sels d'addition d'acides, a action carcinostatique, et procedes pour les preparer
JPH04244083A (ja) 三環状ピリドン誘導体
US4578377A (en) Derivatives of cephalosporins, their process of separation and antibiotic drugs containing the said derivatives
CN111072740B (zh) 红霉素a酮内酯类抗生素衍生物、其制备方法及应用
KR930003611B1 (ko) 퀴놀론 카복실산 유도체의 제조방법
US4064270A (en) N'-(Aminoacylaminophenyl) acetamidines
JPS63166876A (ja) ピリドンカルボン酸誘導体
PL108305B1 (en) Method of producing new erythromycin derivatives
US3647779A (en) Kasugamycin substituted antibacterial agents
KR0147888B1 (ko) 3-(1-아미노시클로알킬)피롤리딘 유도체 및 이의 제조방법
JPH0437073B2 (OSRAM)